Naohisa Tomosugi

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

Hisanori Umehara, Kazuichi Okazaki, Yasufumi Masaki et al. · Modern Rheumatology · 2012 · 691 citations · Full text

Life Sciences, Nephrology, Pathology +13

Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

Soken-Nakazawa J. Song, Naohisa Tomosugi, Hiroshi Kawabata et al. · Blood · 2010 · 226 citations · Full text

Life Sciences, Hematology, Immunology +16

Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1.

Naohisa Tomosugi, S. J. Cashman, Hay H et al. · The Journal of Immunology · 1989 · 182 citations · Full text

Medicine, Immunology, Pathology +17

Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization

Joyce JC Kroot, Erwin Kemna, Sukhvinder S. Bansal et al. · Haematologica · 2009 · 178 citations · Full text

Medicine, Biochemistry, Clinical Biochemistry +8

Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis

Takashi Wada, Kengo Furuichi, Norihiko Sakai et al. · Journal of the American Society of Nephrology · 2004 · 172 citations

Life Sciences, Immunology, Nephrology +17